» Articles » PMID: 35456502

Preferential X Chromosome Inactivation As a Mechanism to Explain Female Preponderance in Myasthenia Gravis

Overview
Journal Genes (Basel)
Publisher MDPI
Date 2022 Apr 23
PMID 35456502
Authors
Affiliations
Soon will be listed here.
Abstract

Myasthenia gravis (MG) is a neuromuscular autoimmune disease characterized by prevalence in young women (3:1). Several mechanisms proposed as explanations for gender bias, including skewed X chromosome inactivation (XCI) and dosage or sex hormones, are often involved in the development of autoimmunity. The skewed XCI pattern can lead to an unbalanced expression of some X-linked genes, as observed in several autoimmune disorders characterized by female predominance. No data are yet available regarding XCI and MG. We hypothesize that the preferential XCI pattern may contribute to the female bias observed in the onset of MG, especially among younger women. XCI analysis was performed on blood samples of 284 women between the ages of 20 and 82. XCI was tested using the Human Androgen Receptor Assay (HUMARA). XCI patterns were classified as random (XCI < 75%) and preferential (XCI ≥ 75%). In 121 informative patients, the frequency of skewed XCI patterns was 47%, significantly higher than in healthy controls (17%; p ≤ 0.00001). Interestingly, the phenomenon was observed mainly in younger patients (<45 years; p ≤ 0.00001). Furthermore, considering the XCI pattern and the other clinical characteristics of patients, no significant differences were found. In conclusion, we observed preferential XCI in MG female patients, suggesting its potential role in the aetiology of MG, as observed in other autoimmune diseases in women.

Citing Articles

Risk of Exacerbation and Level of Healthcare Resource Utilization in Myasthenia Gravis Assessed by Myasthenia Gravis Activities of Daily Living Score.

Ting A, Park M, Sangha O, Kumar M, Ricci J, Lee E Neurol Ther. 2025; 14(2):575-591.

PMID: 39961947 PMC: 11906949. DOI: 10.1007/s40120-025-00711-3.


Sex Differences on the Pharmacokinetics of Drugs for Children with Chronic Kidney Disease: A Narrative Review.

Faghihi T, Assadi F Adv Pharm Bull. 2024; 14(3):537-542.

PMID: 39494256 PMC: 11530871. DOI: 10.34172/apb.2024.056.


Sexual dimorphisms in skeletal muscle: current concepts and research horizons.

Emmert M, Emmert A, Goh Q, Cornwall R J Appl Physiol (1985). 2024; 137(2):274-299.

PMID: 38779763 PMC: 11343095. DOI: 10.1152/japplphysiol.00529.2023.


Development and application of haploid embryonic stem cells.

Wang H, Ma X, Guo Y Stem Cell Res Ther. 2024; 15(1):116.

PMID: 38654389 PMC: 11040874. DOI: 10.1186/s13287-024-03727-y.


Correlation of fatigue on walking ability in myasthenia gravis patients: a cross-sectional study.

Kartika L, Subadi I, Pawana I, Andriana M, Sugianto P Ann Med Surg (Lond). 2024; 86(1):115-120.

PMID: 38222720 PMC: 10783269. DOI: 10.1097/MS9.0000000000001508.


References
1.
Tukiainen T, Villani A, Yen A, Rivas M, Marshall J, Satija R . Landscape of X chromosome inactivation across human tissues. Nature. 2017; 550(7675):244-248. PMC: 5685192. DOI: 10.1038/nature24265. View

2.
Shvetsova E, Sofronova A, Monajemi R, Gagalova K, Draisma H, White S . Skewed X-inactivation is common in the general female population. Eur J Hum Genet. 2018; 27(3):455-465. PMC: 6460563. DOI: 10.1038/s41431-018-0291-3. View

3.
Melzer N, Ruck T, Fuhr P, Gold R, Hohlfeld R, Marx A . Clinical features, pathogenesis, and treatment of myasthenia gravis: a supplement to the Guidelines of the German Neurological Society. J Neurol. 2016; 263(8):1473-94. PMC: 4971048. DOI: 10.1007/s00415-016-8045-z. View

4.
Li G, Su Q, Liu G, Gong L, Zhang W, Zhu S . Skewed X chromosome inactivation of blood cells is associated with early development of lung cancer in females. Oncol Rep. 2006; 16(4):859-64. View

5.
Invernizzi P, Pasini S, Selmi C, Miozzo M, Podda M . Skewing of X chromosome inactivation in autoimmunity. Autoimmunity. 2008; 41(4):272-7. DOI: 10.1080/08916930802024574. View